{
    "ticker": "ASAZY",
    "name": "AstraZeneca PLC",
    "description": "AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. Founded in 1999 through a merger between Astra AB and Zeneca Group PLC, the company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca\u2019s portfolio includes drugs across various therapeutic areas including oncology, cardiovascular, renal, respiratory, and immunology. The company's mission is to push the boundaries of science to deliver life-changing medicines and improve patient outcomes. AstraZeneca is committed to addressing public health challenges, including the COVID-19 pandemic, through the development of vaccines and therapeutics. The company places a strong emphasis on research and development, investing heavily in new technologies and collaborations with academic institutions, biotechnology companies, and other partners to accelerate the pace of innovation. AstraZeneca is also focused on sustainability, aiming to minimize its environmental impact while ensuring access to medicines globally.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Cambridge, England, UK",
    "founded": "1999",
    "website": "https://www.astrazeneca.com",
    "ceo": "Pascal Soriot",
    "social_media": {
        "twitter": "https://twitter.com/AstraZeneca",
        "linkedin": "https://www.linkedin.com/company/astrazeneca/"
    },
    "investor_relations": "https://www.astrazeneca.com/investors.html",
    "key_executives": [
        {
            "name": "Pascal Soriot",
            "position": "CEO"
        },
        {
            "name": "Mene Pangalos",
            "position": "Executive Vice President, BioPharmaceuticals R&D"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "Tagrisso",
                "Imfinzi",
                "Lynparza"
            ]
        },
        {
            "category": "Cardiovascular",
            "products": [
                "Brilinta",
                "Farxiga"
            ]
        },
        {
            "category": "Respiratory",
            "products": [
                "Symbicort",
                "Fasenra"
            ]
        }
    ],
    "seo": {
        "meta_title": "AstraZeneca PLC | Global Biopharmaceutical Company",
        "meta_description": "Explore AstraZeneca PLC, a leading biopharmaceutical company dedicated to delivering life-changing medicines across various therapeutic areas. Learn about our commitment to innovation and sustainability.",
        "keywords": [
            "AstraZeneca",
            "Pharmaceuticals",
            "Biotechnology",
            "Oncology",
            "COVID-19 Vaccine",
            "Life-changing Medicines"
        ]
    },
    "faq": [
        {
            "question": "What is AstraZeneca known for?",
            "answer": "AstraZeneca is known for its innovative prescription medicines in areas such as oncology, cardiovascular, and respiratory diseases."
        },
        {
            "question": "Who is the CEO of AstraZeneca?",
            "answer": "Pascal Soriot is the CEO of AstraZeneca PLC."
        },
        {
            "question": "Where is AstraZeneca headquartered?",
            "answer": "AstraZeneca is headquartered in Cambridge, England, UK."
        },
        {
            "question": "What are AstraZeneca's main products?",
            "answer": "AstraZeneca's main products include Tagrisso, Imfinzi, Farxiga, and Brilinta."
        },
        {
            "question": "When was AstraZeneca founded?",
            "answer": "AstraZeneca was founded in 1999."
        }
    ],
    "competitors": [
        "PFE",
        "JNJ",
        "MRK",
        "GILD"
    ],
    "related_stocks": [
        "ABBV",
        "BMY",
        "AMGN",
        "NOVN"
    ]
}